The add-on effect of solifenacin for patients with remaining overactive bladder after treatment with tamsulosin for lower urinary tract symptoms suggestive of benign prostatic obstruction

Advances in Urology

Volumn , Issue , 2010, Pages

  Masumori, Naoya ^a   Tsukamoto, Taiji ^a   Yanase, Masahiro ^b   Horita, Hiroki ^c   Aoki, Masaharu ^d  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Sunagawa City Hospital   (Japan)

^c Otaru Hokusei Hospital   (Japan)

^d Kushiro Red Cross Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78650784971     PISSN: 16876369     EISSN: 16876377     Source Type: Journal    
DOI: 10.1155/2010/205251     Document Type: Article

References (23)

1. Lee J. Y., Kim H. W., Lee S. J., Koh J. S., Suh H. J., Chancellor M. B., Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder BJU International 2004 94 6 817 820
2. Astellas Pharma Inc., J-TIPS: Japan-tamsulosin I-PSS survey Journalof New Remedies Clinics 2006 55 403 426
3. Masumori N., Sato Y., Itoh N., Clinical efficacy of naftopidil for benign prostatic hyperplasia - the effect on storage symptoms Japanese Journal of Urology 2004 17 335 344
4. Homma Y., Araki I., Igawa Y., Clinical guideline for male lower urinary tract symptoms International Journal of Urology 2009 16 775 790
5. Abrams P., Kaplan S., De Koning Gans H. J., Millard R., Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction Journal of Urology 2006 175 3 999 1004 (Pubitemid 43200054)
6. Kaplan S. A., Walmsley K., Te A. E., Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia Journal of Urology 2005 174 6 2273 2275
7. Athanasopoulos A., Gyftopoulos K., Giannitsas K., Fisfis J., Perimenis P., Barbalias G., Combination treatment with an -blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized, controlled study Journal of Urology 2003 169 6 2253 2256
8. Lee K.-S., Choo M.-S., Kim D.-Y., Kim J. C., Kim H.-J., Min K. S., Lee J. B., Jeong H. J., Lee T., Park W. H., Combination treatment with propiverine hydrochloride plus doxazosin controlled release gastrointestinal therapeutic system formulation for overactive bladder and coexisting benign prostatic obstruction: a prospective, randomized, controlled multicenter study Journal of Urology 2005 174 1334 1338
9. Kaplan S. A., Roehrborn C. G., Rovner E. S., Carlsson M., Bavendam T., Guan Z., Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial Journal of the American Medical Association 2006 296 19 2319 2328
10. Rovner E. S., Kreder K., Sussman D. O., Kaplan S. A., Carlsson M., Bavendam T., Guan Z., Effect of tolterodine extended release with or without tamsulosin on measures of urgency and patient reported outcomes in men with lower urinary tract symptoms Journal of Urology 2008 180 3 1034 1041
11. Chapple C., Herschorn S., Abrams P., Sun F., Brodsky M., Guan Z., Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with -blockers European Urology 2009 56 3 534 543
12. Kaplan S. A., McCammon K., Fincher R., Fakhoury A., He W., Safety and tolerability of solifenacin add-on therapy to -blocker treated men with residual urgency and frequency Journal of Urology 2009 182 6 2825 2830
13. McConnell J., Abrams P., Khoury S., McConnell J., 6th International Consultation on New Developments in Prostate Cancer and Prostate Diseases. Recommendations of the international scientific committee: evaluation and treatment of lower urinary tract symptoms (LUTS) in old men Male Lower Urinary Tract Dysfunction Evaluation and Management 2006 21st France 387 401
14. Yamaguchi O., Marui E., Kakizaki H., Itoh N., Yokota T., Okada H., Ishizuka O., Ozono S., Gotoh M., Sugiyama T., Seki N., Yoshida M., Randomized, double-blind, placebo-and propiverine-controlled trial of the once-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder BJU International 2007 100 3 579 587
15. Homma Y., Yoshida M., Seki N., Yokoyama O., Kakizaki H., Gotoh M., Yamanishi T., Yamaguchi O., Takeda M., Nishizawa O., Symptom assessment tool for overactive bladder syndrome-overactive bladder symptom score Urology 2006 68 2 318 323
16. Sugiyama T., Shimizu N., Yoshioka N., Hanai T., Matsumoto S., Uemura T., The treatment of overactive bladder symptoms related to benign prostatic hyperplasia with an anticholineric agents Neurogenic Bladder Society 2004 15 191 197
17. Yoshida M., Inadome A., Nagata T., Maeda Y., Stoji Y., Masunaga K., The efficacy and safety for the combination therapy with tamsulosin hydorchloride and solifenacin succinate in benign prostatic hyperplasia patients with overactive bladder Japanese Journal of Urological Surgery 2008 21 603 611
18. Kakizaki H., Wada N., Numata A., Compariosn of tamsulosin with or without solifenacin in men with benign prostatic hyperplasia and overactive bladder: short-term results on efficacy and safety Japanese Journal of Urological Surgery 2008 21 709 716
19. Naya Y., Ushijima S., Kanazawa M., Long-term study of combination of tamsulosin 0.2mg/day and solifenacin 5mg/day in patients with overactive bladder associated with benign prostatic hyperplasia Japanese Journal of Urological Surgery 2009 22 145 150
20. Tsujimura A., Takao T., Uchida K., Clinical efficacy of tolterodine for patients with overactive bladder after in sufficient efficacy by monotherapy with 1-adrenoceptor antagonist Japanese Journal of Urological Surgery 2009 100 689 692
21. Nishino Y., Kikuchi M., Masue T., Miwa K., Deguchi T., Moriyama Y., Combination therapy with an 1 adrenergic antagonist and an anti-cholinergic agent for patients with prostatic hypertrophy associated with an overactive bladder: combined effects of silodosin and imidafenacin Japanese Journal of Clinical Urology 2009 63 9 719 726
22. Sumino Y., Fujita Y., Yamasaki M., Evaluation of imidafenacin in patients with overactive bladder due to benign prostatic hyperplasia Japanese Journal of Urological Surgery 2010 23 39 43
23. Nishizawa O., Yamaguchi O., Yakeda M., Yokoyama O., Trial of combination treatment with an alpha-blocker plus anticholinergic for BPH with OAB Neurogenic Bladder Society 2009 20 288